These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28202010)

  • 21. Flexible parametric copula modeling approaches for clustered survival data.
    Kwon S; Ha ID; Shih JH; Emura T
    Pharm Stat; 2022 Jan; 21(1):69-88. PubMed ID: 34342391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression modeling of semicompeting risks data.
    Peng L; Fine JP
    Biometrics; 2007 Mar; 63(1):96-108. PubMed ID: 17447934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of acupuncture treatment in patients with headache.
    Witt CM; Reinhold T; Jena S; Brinkhaus B; Willich SN
    Cephalalgia; 2008 Apr; 28(4):334-45. PubMed ID: 18315686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate?
    Pullenayegum EM; Tarride JE; Xie F; Goeree R; Gerstein HC; O'Reilly D
    Value Health; 2010; 13(4):487-94. PubMed ID: 20230549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copula-based regression models for a bivariate mixed discrete and continuous outcome.
    de Leon AR; Wu B
    Stat Med; 2011 Jan; 30(2):175-85. PubMed ID: 20963753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study on confidence intervals for incremental cost-effectiveness ratios.
    Wang H; Zhao H
    Biom J; 2008 Aug; 50(4):505-14. PubMed ID: 18663759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Median-based incremental cost-effectiveness ratios with censored data.
    Bang H; Zhao H
    J Biopharm Stat; 2016; 26(3):552-64. PubMed ID: 26010599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 3-Year Cost-Effectiveness of a Nurse-Based Case Management versus Usual Care for Elderly Patients with Myocardial Infarction: Results from the KORINNA Follow-Up Study.
    Seidl H; Hunger M; Meisinger C; Kirchberger I; Kuch B; Leidl R; Holle R
    Value Health; 2017 Mar; 20(3):441-450. PubMed ID: 28292489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incremental cost-effectiveness of adult spinal deformity surgery: observed quality-adjusted life years with surgery compared with predicted quality-adjusted life years without surgery.
    McCarthy I; O'Brien M; Ames C; Robinson C; Errico T; Polly DW; Hostin R;
    Neurosurg Focus; 2014 May; 36(5):E3. PubMed ID: 24785485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conditional copula models for right-censored clustered event time data.
    Geerdens C; Acar EF; Janssen P
    Biostatistics; 2018 Apr; 19(2):247-262. PubMed ID: 28968642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of asthma control: an economic appraisal of the GOAL study.
    Briggs AH; Bousquet J; Wallace MV; Busse WW; Clark TJ; Pedersen SE; Bateman ED;
    Allergy; 2006 May; 61(5):531-6. PubMed ID: 16629780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seven-year cost-effectiveness of ProDisc-C total disc replacement: results from investigational device exemption and post-approval studies.
    Radcliff K; Lerner J; Yang C; Bernard T; Zigler JE
    J Neurosurg Spine; 2016 May; 24(5):760-8. PubMed ID: 26824587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness for acupuncture in seasonal allergic rhinitis: economic results of the ACUSAR trial.
    Reinhold T; Roll S; Willich SN; Ortiz M; Witt CM; Brinkhaus B
    Ann Allergy Asthma Immunol; 2013 Jul; 111(1):56-63. PubMed ID: 23806461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A two-part model for censored medical cost data.
    Tian L; Huang J
    Stat Med; 2007 Oct; 26(23):4273-92. PubMed ID: 17330248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twice-weighted multiple interval estimation of a marginal structural model to analyze cost-effectiveness.
    Goldfeld KS
    Stat Med; 2014 Mar; 33(7):1222-41. PubMed ID: 24151161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Semiparametric estimation in copula models for bivariate sequential survival times.
    Lawless JF; Yilmaz YE
    Biom J; 2011 Sep; 53(5):779-96. PubMed ID: 21887793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonparametric inference for median costs with censored data.
    Zhao H; Zuo C; Chen S; Bang H
    Biometrics; 2012 Sep; 68(3):717-25. PubMed ID: 22364557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Boosting distributional copula regression.
    Hans N; Klein N; Faschingbauer F; Schneider M; Mayr A
    Biometrics; 2023 Sep; 79(3):2298-2310. PubMed ID: 36165288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Slope estimation for informatively right censored longitudinal data modelling the number of observations using geometric and Poisson distributions: application to renal transplant cohort.
    Jaffa MA; Lipsitz S; Woolson RF
    Stat Methods Med Res; 2015 Dec; 24(6):819-35. PubMed ID: 22143404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.